论文部分内容阅读
目的研究腹腔胃肠道恶性肿瘤术后腹腔联合化疗较传统静脉全身化疗的优势。方法比较5年来腹腔恶性肿瘤根治术后腹腔联合化疗和静脉化疗的生存率复发率的差异。结果腹腔胃肠道恶性肿瘤术后腹腔联合化疗组患者1、2、3年生存率疗效明显高于静脉化疗组,复发率也具有显著性差异。结论胃肠道恶性肿瘤根治术后腹腔联合化疗优于静脉全身化疗。
Objective To study the advantages of postoperative abdominal combined chemotherapy in traditional Chinese medicine for the treatment of abdominal gastrointestinal cancer compared with traditional intravenous systemic chemotherapy. Methods The difference of survival rate after peritoneal chemotherapy and intravenous chemotherapy after radical resection of abdominal cancer in 5 years was compared. Results The 1, 2, 3-year survival rates of patients with intraperitoneal gastrointestinal cancer after surgery combined with intraperitoneal chemotherapy were significantly higher than those of intravenous chemotherapy group, and the recurrence rate was also significantly different. Conclusions Intraperitoneal chemotherapy is better than intravenous systemic chemotherapy after radical operation of gastrointestinal cancer.